Antibody Research

Monoclonal antibodies have become important treatments for cancer, inflammation and a wide range of other diseases, representing an increasing share of the most successful pharmaceutical markets. Monoclonal antibodies (mAbs) are remarkably versatile protein molecules with numerous applications in human health. More than 30 mAb therapeutics have been approved for marketing and approximately 360 mAbs are currently in clinical studies, with 30 in pivotal trials. The global monoclonal antibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024, a growth rate of 5.7% over the forecast period.



  • Antibody Protein Engineering
  • Challenges in Antibody Discovery
  • Antibody Drug Development
  • Monoclonal antibody.
  • Monoclonal antibody.
  • Antibodies role in epigenetic.
  • Polyclonal antibody.

Related Conference of Antibody Research

Antibody Research Conference Speakers